CAFARO, Giacomo
 Distribuzione geografica
Continente #
NA - Nord America 1.784
AS - Asia 1.605
EU - Europa 1.008
SA - Sud America 273
AF - Africa 49
Totale 4.719
Nazione #
US - Stati Uniti d'America 1.730
SG - Singapore 805
IE - Irlanda 237
BR - Brasile 220
RU - Federazione Russa 201
HK - Hong Kong 197
IT - Italia 181
CN - Cina 174
VN - Vietnam 147
FR - Francia 118
KR - Corea 74
DE - Germania 49
SE - Svezia 48
IN - India 40
FI - Finlandia 35
GB - Regno Unito 35
BD - Bangladesh 29
CA - Canada 29
AR - Argentina 23
JP - Giappone 22
ZA - Sudafrica 19
PL - Polonia 17
IQ - Iraq 16
UZ - Uzbekistan 15
NL - Olanda 14
MX - Messico 13
TR - Turchia 13
UA - Ucraina 13
CH - Svizzera 12
EC - Ecuador 12
ES - Italia 11
PK - Pakistan 11
ID - Indonesia 9
SA - Arabia Saudita 8
KE - Kenya 7
PH - Filippine 7
MY - Malesia 6
AT - Austria 5
CO - Colombia 5
EG - Egitto 5
VE - Venezuela 5
HU - Ungheria 4
IL - Israele 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
PT - Portogallo 4
BG - Bulgaria 3
LB - Libano 3
PA - Panama 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
JO - Giordania 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
RO - Romania 2
SY - Repubblica araba siriana 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
CU - Cuba 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GM - Gambi 1
GR - Grecia 1
GY - Guiana 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
UG - Uganda 1
Totale 4.719
Città #
Singapore 561
Dublin 234
San Jose 228
Hong Kong 193
Ashburn 186
Chandler 176
San Mateo 89
Moscow 82
Boardman 81
Santa Clara 75
Seoul 74
Dong Ket 70
Lauterbourg 59
Los Angeles 54
Altamura 50
New York 42
Lawrence 40
Medford 40
Princeton 40
The Dalles 36
Wilmington 33
Beijing 32
Perugia 32
São Paulo 28
Piscataway 24
Hanoi 22
Helsinki 20
Munich 19
Ho Chi Minh City 18
Tokyo 17
Falls Church 16
Montreal 16
Andover 13
San Paolo di Civitate 13
Warsaw 13
Council Bluffs 12
Johannesburg 12
Tashkent 12
Brooklyn 11
Chicago 11
Saint Petersburg 11
Atlanta 10
Des Moines 10
San Francisco 10
Baghdad 9
Dallas 9
Milan 9
Rio de Janeiro 9
Amsterdam 8
Columbus 8
Nuremberg 8
Orem 8
Shanghai 8
Stockholm 8
Boston 7
Dhaka 7
Hefei 7
Norwalk 7
Poplar 7
Chennai 6
Denver 6
Houston 6
Manchester 6
Mexico City 6
Salvador 6
Belo Horizonte 5
Frankfurt am Main 5
Jeddah 5
London 5
Menlo Park 5
Nairobi 5
Quito 5
Redmond 5
Redwood City 5
Turku 5
Ankara 4
Bologna 4
Buenos Aires 4
Frankfurt Am Main 4
Guayaquil 4
Haiphong 4
Lappeenranta 4
New Delhi 4
Reggio Emilia 4
Secaucus 4
Tel Aviv 4
Vicenza 4
Almaty 3
Barnet 3
Cadoneghe 3
Campinas 3
Charlotte 3
Da Nang 3
Florence 3
Hyderabad 3
Hải Dương 3
Juiz de Fora 3
Kuala Lumpur 3
Maceió 3
Mainz 3
Totale 3.117
Nome #
Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario? 122
A Platelet's Guide to Synovitis 109
Microbiota and arthritis: cause or consequence? 100
The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndrome 98
DETERMINATION OF TRPV1+/T LYMPHOCYTES IN INFLAMMATORY ARTHRITIS AND THEIR CORRELATION WITH ULTRASOUND FINDINGS 96
Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: A pilot study 96
Association Between Glandular Infiltrate and Leukopenia in Sjögren Syndrome (SS): Data From the Italian Research Group on SS (GRISS) 95
Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling. 93
Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future 93
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy 87
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 85
Extra-articular rheumatoid arthritis 84
One year in review 2019: Sjögren's syndrome 84
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 84
Correspondence on a € Anti-inflammatory therapy for COVID-19 infection: The case for colchicine' 84
Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality? 83
A 23-Plex Cytokine/Chemokine Analysis Identifies TNFRII, MMP-8, and sIL-1RII as Potential Biomarkers for Systemic Sclerosis 81
BCL2-associated athanogene 3 protein is associated with B-cell hyperactivity including lymphoma in primary sjÖgren's syndrome 81
Intravenous immunoglobulins at the crossroad of autoimmunity and viral infections 81
Combined semiquantitative nail-enthesis complex ultrasonography and capillaroscopy in psoriasis and psoriatic arthritis 81
Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome 79
Platelets: a potential target for rheumatoid arthritis treatment? 78
Salivary Gland Ultrasonography in Sjögren's Syndrome: A European Multicenter Reliability Exercise for the HarmonicSS Project 78
Effect of Sinovial High-Low® injections in trapeziometacarpal osteoarthritis 76
Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica 74
Drugs in induction and treatment of idiopathic inflammatory myopathies. 74
Central Hemodynamics and Arterial Stiffness in Systemic Sclerosis 74
Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjögren's syndrome 74
One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren's syndrome 74
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 73
Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters 72
Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases 72
Subclinical atherosclerosis in primary Sjögren's syndrome: Does inflammation matter? 70
Hypertension and SARS-CoV-2 infection: is inflammation the missing link? 69
Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjögren's syndrome and rheumatoid arthritis 68
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment 67
Cardiovascular risk in systemic autoimmune diseases 66
Sjögren's syndrome: one year in review 2022 66
Cardiovascular Involvement in Sjögren's Syndrome 66
Ultrasound scoring systems affect the distribution of sialadenitis scores in Sjögren's syndrome: an inter-system reproducibility study 65
The facts and fictions of precision medicine in autoimmune diseases: is the machine learning approach the response? 65
Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren's Syndrome 64
One year in review 2018: Sjogren's syndrome. 64
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis 63
Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy 62
OP0044 Antibodies anti-saccharomyces cerevisiae in primary sjÖgren's syndrome: prevalence, clinical associations and possible cross-reactivity with disease specific autoantigens 62
Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy 61
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 59
One year in review 2021: Sjögren's syndrome 59
Novel self-amplificatory loop between T cells and tenocytes as a driver of chronicity in tendon disease 58
One year in review 2016: Sjögren's syndrome 58
Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sjögren's syndrome 56
Insulin-like growth factor binding protein 6 in rheumatoid arthritis: A possible novel chemotactic factor? 55
Psoriatic arthritis: tissue-directed inflammation? 53
The clinical spectrum of primary sjogren's syndrome: Beyond exocrine glands 53
Salivary gland biopsy as a prognostic tool in Sjögren’s syndrome 52
The onset site of rheumatoid arthritis: The joints or the lung? 52
Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study 51
Cardiovascular risk in patients with Sjögren's syndrome: is it time for a new approach? 50
Primary Sjögren's syndrome in Italy: Real-world evidence of a rare disease through administrative healthcare data 49
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon 48
Comment on: "Gluten or no gluten for rheumatic diseases?‿ by Philippou E et al. 48
Impact of gender and age at onset on Sjögren's syndrome presentation and outcome: state of the art 46
Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet’s disease and autoinflammation. A viewpoint 46
Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review 46
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 45
Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases 45
Sjogren's syndrome: Everything you always wanted to know about genetic and epigenetic factors 44
An overview of how ultrasound can guide treatment for patients with rheumatoid and psoriatic arthritis 25
Phenotypic clusters of long-term damage in Sjögren’s disease: a 15-year multicentre study 19
Autoimmune hypophysitis 18
Clinical and serological differences of an Italian Sjögren's disease cohort according to three geographic macro-area localisations 12
Simultaneous onset of systemic sclerosis and light chain amyloidosis: the first report of a case report and review of the literature 11
Totale 4.851
Categoria #
all - tutte 22.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 0 0 0 0 0 0 3 3 71
2021/2022314 3 61 4 9 23 12 4 72 7 12 56 51
2022/2023660 41 133 7 56 59 55 2 23 245 1 31 7
2023/2024350 21 40 8 21 5 37 80 4 29 14 46 45
2024/20251.024 29 90 19 40 120 57 40 80 249 62 159 79
2025/20262.212 161 152 157 273 299 204 427 144 210 185 0 0
Totale 4.851